--- title: "Tenet Healthcare Shares Climb 15% On Q2 Profit Growth, Lifts FY26 Outlook - Update" type: "News" locale: "en" url: "https://longbridge.com/en/news/293750069.md" description: "Tenet Healthcare shares surged over 15% in pre-market trading after reporting strong Q2 earnings and raising its FY26 outlook. Net income rose to $826 million from $288 million year-over-year, with EPS increasing to $9.84. The company updated its full-year guidance, projecting higher net operating revenues, net income, and adjusted earnings per share compared to previous estimates." datetime: "2026-07-24T11:34:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293750069.md) - [en](https://longbridge.com/en/news/293750069.md) - [zh-HK](https://longbridge.com/zh-HK/news/293750069.md) --- # Tenet Healthcare Shares Climb 15% On Q2 Profit Growth, Lifts FY26 Outlook - Update Add as your preferred news source on Google Add Now Shares of Tenet Healthcare Corp. (THC) were gaining around 15% in the pre-market activity on the NYSE, after the company reported higher earnings in second quarter and raised its outlook for full year of 2026. In the pre-market activity on the NYSE, the shares were trading 15.51 percent higher at $230.00, after closing Thursday's regular trading 1.88 percent up. Net income available to the company's shareholders increased to $826 million, from $288 million in the same quarter last year. Earnings per share went up to $9.84, from $3.14 a year ago. Adjusted net income available to the company's shareholders rose to $514 million from $369 million previous year. Adjusted earnings per shares were $6.12, compared to $4.02 a year ago. Adjusted EBITDA was $1.30 billion, up from $1.12 billion last year. Net operating revenue for the period increased by 6.8 percent to $5.63 billion from $5.27 billion last year. The growth reflects increase in adjusted admissions and higher acuity, partially offset by unfavorable payer mix. In the updated outlook, the company expects net operating revenues to be between $21.9 billion and $22.5 billion, which is higher than the previously announced guidance range of $21.5 billion to $22.3 billion. The net income available for the shareholders is expected to be between $2.87 billion and $3.02 billion, which is above the previous guidance range of $2.61 billion to $2.84 billion. The earnings per share are expected to be between $34.57 and $36.43, which is higher than the prior guidance of $29.94 to $32.64. The adjusted net income is expected to be in the range of $1.69 billion to $1.80 billion, which is above the previous guidance of $1.43 billion to $1.63 billion. Adjusted earnings per shares is projected to be between $20.30 and $21.69, which is higher than the guidance range of $16.38 to $18.68. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com. For comments and feedback contact: editorial@rttnews.com Business News ### Related Stocks - [THC.US](https://longbridge.com/en/quote/THC.US.md) ## Related News & Research - [THC: Q2 2026 delivered robust profit and margin growth, prompting higher FY 2026 guidance and a $2B buyback boost](https://longbridge.com/en/news/293661477.md) - [Tenet Healthcare (THC) Stock Faces Cautious Narratives Despite Strong Q2 EPS And Margin Performance](https://longbridge.com/en/news/293823409.md) - [BUZZ-Tenet Healthcare jumps after lifting annual forecast](https://longbridge.com/en/news/293741662.md) - [Arrowstreet Capital Limited Partnership Increases Stock Position in Tenet Healthcare Corporation $THC](https://longbridge.com/en/news/293838073.md) - [Tenet Healthcare director Christopher S. Lynch sells 3,837 shares for $934,080.48](https://longbridge.com/en/news/294126379.md)